Cipriano R Gama, Andre S Franco, Adriana B Bortoluzzo, Renata Miossi, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino Assad, Percival D Sampaio-Barros
{"title":"Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective Analysis.","authors":"Cipriano R Gama, Andre S Franco, Adriana B Bortoluzzo, Renata Miossi, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino Assad, Percival D Sampaio-Barros","doi":"10.3899/jrheum.2024-0505","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Systemic sclerosis (SSc) often presents alongside other connective tissue disorders, termed \"overlap syndrome (OS).\" This study aimed to characterize patients with SSc with OS compared to those without OS in a tertiary university hospital in Brazil.</p><p><strong>Methods: </strong>A retrospective analysis of demographic, clinical, and laboratory data from 787 SSc patients was performed using electronic medical records. Patients were classified based on the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc and additional criteria for systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM), Sjögren disease (SjD), and rheumatoid arthritis (RA). Statistical analysis, including univariate and multivariate methods, identified factors associated with OS.</p><p><strong>Results: </strong>Ninety-one patients (11.6%) had OS, mainly with SLE (29.7%), SjD (26.4%), RA (24.2%), or IIM (19.8%). Patients with OS were younger, with an earlier age at onset (<i>P</i> = 0.004) and at diagnosis (<i>P</i> = 0.003). They presented a higher prevalence of limited SSc (<i>P</i> <sub>trend</sub> = 0.06), musculoskeletal symptoms (<i>P</i> < 0.001), neoplasia (<i>P</i> = 0.03), and sicca symptoms (<i>P</i> < 0.001); and were associated with a lower frequency of pulmonary hypertension (<i>P</i> = 0.048) and comorbidities such as diabetes mellitus (<i>P</i> = 0.02) and dyslipidemia (<i>P</i> = 0.02). A higher prevalence of anti-Ro (<i>P</i> = 0.007) and a lower prevalence of anti-Scl70 (<i>P</i> = 0.003) were also observed. Patients with OS were more frequently prescribed glucocorticoids (GCs; <i>P</i> < 0.001), methotrexate (<i>P</i> = 0.01), and leflunomide (<i>P</i> = 0.001). Multivariate analysis identified limited SSc (odds ratio [OR] 3.1), neoplasia (OR 3.4), and use of GCs (OR 8.2) and leflunomide (OR 5.5) with OS. No worse prognosis was observed.</p><p><strong>Conclusion: </strong>Overall, Brazilian patients with SSc with OS have distinct clinical characteristics but do not have a worse prognosis compared to those without OS.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-0505","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Systemic sclerosis (SSc) often presents alongside other connective tissue disorders, termed "overlap syndrome (OS)." This study aimed to characterize patients with SSc with OS compared to those without OS in a tertiary university hospital in Brazil.
Methods: A retrospective analysis of demographic, clinical, and laboratory data from 787 SSc patients was performed using electronic medical records. Patients were classified based on the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc and additional criteria for systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM), Sjögren disease (SjD), and rheumatoid arthritis (RA). Statistical analysis, including univariate and multivariate methods, identified factors associated with OS.
Results: Ninety-one patients (11.6%) had OS, mainly with SLE (29.7%), SjD (26.4%), RA (24.2%), or IIM (19.8%). Patients with OS were younger, with an earlier age at onset (P = 0.004) and at diagnosis (P = 0.003). They presented a higher prevalence of limited SSc (Ptrend = 0.06), musculoskeletal symptoms (P < 0.001), neoplasia (P = 0.03), and sicca symptoms (P < 0.001); and were associated with a lower frequency of pulmonary hypertension (P = 0.048) and comorbidities such as diabetes mellitus (P = 0.02) and dyslipidemia (P = 0.02). A higher prevalence of anti-Ro (P = 0.007) and a lower prevalence of anti-Scl70 (P = 0.003) were also observed. Patients with OS were more frequently prescribed glucocorticoids (GCs; P < 0.001), methotrexate (P = 0.01), and leflunomide (P = 0.001). Multivariate analysis identified limited SSc (odds ratio [OR] 3.1), neoplasia (OR 3.4), and use of GCs (OR 8.2) and leflunomide (OR 5.5) with OS. No worse prognosis was observed.
Conclusion: Overall, Brazilian patients with SSc with OS have distinct clinical characteristics but do not have a worse prognosis compared to those without OS.
期刊介绍：
The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
